Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
LEU001 / Leucid Bio
NCT01818323: Phase I Trial: T4 Immunotherapy of Head and Neck Cancer	Recruiting	1	30	Europe	Intra-tumoral T4 immunotherapy, 4ab T1E28z positive T-cells	King's College London, Guy's and St Thomas' NHS Foundation Trust	Head and Neck Cancer	12/24	01/25